Info

I. X.-S. Chen, T. A. Naumann, U. Kurre, N. A. Jenkins, N. G. Copeland, and C. D. Funk, J. Biol. Chem., 270, 17993 (1995).

109. J. L. Goulet, J. N. Snouwaert, A. M. Latour, T. M. Coffman, and B. H. Koller, Proc. Natl. Acad. Sci. USA, 91,12852 (1994).

110. (a) A. Goetze, L. Fay er, J. Bouska, D. Bornemeier, and G. Carter, Prostaglandins, 29,689 (1985); (b) C. Rouzer and B. Sarnuelsson, Proc. Natl. Acad. Sci. USA, 82,6040 (1985).

111. J.-P. Falgueyret, D. Denis, D. Macdonald, J. H. Hutchinson, and D. Riendeau, Biochemistry, 34, 13603 (1995).

112. C. D. Funk, H. Günne, et al., Proc. Natl. Acad. Sci. USA, 86,2592 (1989).

113. T. Nguyen, J.-P. Falgueyret, et al., J. Biol. Chem., 266,22057 (1991).

114. O. RAdmark, J. Lipid Mediat. Cell Signal., 12, 171 (1995).

115. R. Lepley and F. Fitzpatrick, J. Biol. Chem., 269,24163 (1994).

116. C. A. Rouzer and B. Sarnuelsson, Methods En-zymol., 187,312 (1990).

117. D. Steinhilber, Pharm. Acta Helv., 69, 3 (1994).

118. D. Aharony and R. L. Stein, J. Biol. Chem., 261,11512 (1986).

119. M. O. Funk, R. T. Carroll, J. F. Thompson, R. H. Sands, and W. R. Durham, J.Am. Chem. Soc., 112,5375 (1990).

120. R. W. Randall, K. E. Eakins, G. A. Higgs, J. A. Salmon, and J. E. Tateson, Agents Actions, 10, 553 (1980).

121. K. Swingle, R. Bell, and G. Moore in K. D. Rainsford, Ed., Antirheumatic and Antiin-

Drugs, Vol. 3, CRC Press, Boca Raton, FL, 1985, p. 105.

122. E. J. Corey, J. R. Cashman, S. S. Kantner, and S. W. Wright, J. Am. Chem. Soc., 106, 1053 (1984).

123. J. B. Summers, B. P. Gunn, H. Mazdiyasni, A. M. Goetze, P. R. Young, J. B. Bouska, R. D. Dyer, D. W. Brooks, and G. W. Carter, J. Med. Chem., 38,2121 (1987).

124. J. B. Summers, B. P. Gunn, J. G. Martin, H. Mazdiyasni, A. O. Stewart, P. R. Young, A. M. Goetze, J. B. Bouska, R. D. Dyer, D. W. Brooks, and G. W. Carter, J. Med. Chem., 31,3 (1988).

125. J. B. Summers, B. P. Gunn, J. G. Martin, M. B. Martin, H. Mazdiyasni, A. O. Stewart, P. R. Young, J. B. Bouska, A. M. Goetze, R. D. Dyer, D. W. Brooks, and G. W. Carter, J, Med. Chem., 31, 1960 (1988).

126. W. P. Jackson, P. J. Islip, G. Kneen, A. Pugh, and P. J. Wates, J.Med. Chem., 31,499(1988).

127. A. Payne, W. Jackson, J.Salmon, A. Nichols, et al., Agents Actions, 34, 189 (1991).

128. D. W. Brooks, J. B. Summers, B. P. Gunn, K. E. Rodriques, J. G. Martin, M. B. Martin, H. Mazdiyasni, J. H. Horns, A. O. Stewart, J. L. Moore, P. R. Young, D. H. Albert, J. B. Bouska, P. E. Malo, R. D. Dyer, R. L. Bell, P. R. Rubin, J. Kesterson, and G. W. Carter, Abstracts ofthe International Chemical Congress ofPacificBa-sin Societies, Honolulu, HI, BIOS34 (1989).

129. G. W. Carter, P. R. Young, D. H. Albert, J. B. Bouska, R. D. Dyer, R. L. Bell, J. B. Summers, D. W. Brooks, P. R. Rubin, and J. Kesterson in U. Zor, Z. Naor, and A Danon, Eds., Leukotri-enes and Prostanoids in Health and Disease, New Trends in Lipid Mediators Research, Vol. 3,Karger, Basel, Switzerland, 1989, p. 50.

130. R. L. Bell in G. Folco, B. Samuelsson, and R. Murphy, Eds., Progress in Inflammation Research, Birkhauser Verlag, Switzerland, 1999, p. 235.

131. A O. Stewart, P. A. Bhatia, J. G. Martin, J. B. Summers, K. E. Rodriques, M. B. Martin, J. H. Holms, J. L. Moore, R. A. Craig, T. Kolasa, J. D. Ratajczyk, H. Mazdiyasni, F. A. J. Kerdesky, S. L. DeNinno, R. G. Maki, J. B. Bouska, P. R. Young, C. Lanni, R. L. Bell, G. W. Carter, and C. D. W. Brooks, J. Med. Chem., 40,1955-1968 (1997).

132. L. Garland and S. Hodgson, Adv. Prostaglandin Thromboxane Leukot. Res., 22, 33 (1994).

133. M. Yeadon, F. L. Dougan, A Petrovic, J. E. Beesley, and AN. Payne, Agents Actions, 38,8 (1993).

134. (a) G. W. Carter, P. R. Young, D. H. Albert, J. B. Bouska, R. D. Dyer, R. L. Bell, J. B. Summers, and D. W. Brooks, J. Pharmacol. Exp. Ther., 256, 929 (1991); (b) D. W. Brooks and G. W. Carter in V. J. Merluzzi and J. Adams, Eds., The Search fir Anti-Inflammatory Drugs, Birkhauser Boston, Cambridge, MA, 1995, p. 129.

135. L. Dube, L. Swanson, W. Awni, R. Ochs, R. Bell, and G. Carter in J. Drazen, S. Dahlen, and T. Lee, Eds., 5-Lipoxygenuse Products in Asthma, Marcel Dekker, New York, 1998, p. 391.

136. P. R. Young, R. L. Bell, C. Lanni, J. B. Summers, D. W. Brooks, and G. W. Carter, Eur. J. Pharmacol., 205,259 (1991).

137. M. Namovic, R. Walsh, C. Goodfellow, R. Harris, G. Carter, and R. Bell, Eur. J. Pharmacol., 315, 81 (1996).

138. (a) P. E. Malo, R. L. Bell, T. K. Shaughnessy, J. B. Summers, D. W. Brooks, and G. W. Carter, Pulm. Pharmacol, 7, 73 (1994); (b) W. A. Abraham, A. Ahmed, A Cortes, M. Siel-

czak, W. Hinz, J, Bouska, C. Lanni, and R. L. Bell, Eur. J. Pharmacol, 217,119 (1992).

139. P. R. Rubin, L. Dube, R. A. Braeckman, L. Swanson, R. Hanson, D. Albert, and G. W. Carter in R. N. Ackerman, R. J. Booney, and A. F. Welton, Eds., Progress in Inflammation, Research and Therapy, Birkhauser, Basel, Switzerland, 1991, p. 103.

140. R. A. Braeckman, R. Granneman, P. R. Rubin, and J. Kesterson, J. Clin. Pharmacol, 29,837 (1989).

141. K. P. Hui, I. K. Taylor, G. W. Taylor, P. R. Rubin, J. Kesterson, N. C. Barnes, and P. J. Barnes, Thorax, 46,184 (1991).

142. G. C. Kane, M. Police, J. Cohn, J. J. Murray, J. E. Fish, and C. Peters, J. Allergy Clin. Immunol, 93, A129 (1994).

143. E. Israel, J. Cohn, L. Dube, Zileuton Study Group, J. Am. Med. Assoc, 275,931 (1996).

144. M. Liu, L. Dube, J. Lancaste, Zileuton Study Group, J. Allergy Clin. Immunol., 98, 859 (1996).

145. B. O'Connor, P. Godard, L. Dube, L. Swanson, et al„ Eur. Respir. J.,9,273S (1996).

146. D. J. Sweeney, J. B. Bouska, J, Machinist, R. L. Bell, G. W. Carter, S. Cepa, and H. N. Nellans, DrugMetob. Dispos, 20, 328 (1992).

147. (a) R. L. Bell, J. B. Bouska, P. E. Malo, C. Lanni, R. R. Harris, E. R. Otis, A. O. Stewart, D. W. Brooks, and G. W. Carter, J. Pharmacol. Exp. Ther, 272, 724 (1995); (b) G. W. Carter, R. L. Bell, K. Marsh, C. Lanni, W. M. Awni, J. B. Bouska, A O. Stewart, R. Hansen, L. Dube, and D. W. Brooks, Ann. N. Y. Acad. Sei, 744,262 (1994).

148. J. C. Ojingwa, R. A Braeckman, J. Hui, R. G. Hansen, and P. R. Rubin, Pharm. Res, 9 (Suppl. 10), Abstr. PPDM8192 (1992).

149. (a) C. D. Brooks, A. O. Stewart, A Basha, P. Bhatia, J. D. Ratajczyk, J. G. Martin, R. A. Craig, T. Kalasa, J, B. Bouska, C. Lanni, R. R Harris, P. E. Malo, G.W. Carter, andR. L. Bell, J. Med. CAe/n.,38,4768 (1995); (b) R. Bell, R. Harris, P. Malo, J. Bouska, et al., J. Pharmacol. Exp. Ther.,280, 1366 (1997).

150. B. Lehnigk, K. F. Rabe, R. S. Herst, P. J. Car-pentier, and H. Magnussen, Am. J. Respir. Crit. Care Med., 151, A376 (1995).

151. J. VanSchoor, G. F. Joos, J. C. Kips, R. A. Pau-weis, J. F. Drajesk, and P. J.Carpentier, Am. J. Respir. Crit. Care Med, 151, A376 (1995).

152. T. G. C. Bird, P. Bruneau, G.C. Crawley, M. P. Edwards, S. J. Foster, J. M. Girodeau, J. F. Kingston, and R. M. McMillan, J. Med. Chem, 34,2176 (1991).

153. R M. McMillan, T. G. C. Bird, G. C. Crawley, M. P. Edwards, J. M. Girodeau, J. F. Kingston, and S. J. Foster, Agents Actions, 34, 110

Was this article helpful?

0 0
How to Stop Your Depression Now

How to Stop Your Depression Now

Finally, Retired Clinical Counsellor Reveals the Secrets Successful Psychiatrists and Psychologists Don't Want You to Know. How to Stop Your Depression Now Reclaim Yourself and Live Again Get the Depression Busting Tools You Need To Win the War Against Depression. Depression is an illness that many people often sweep under a rug. However if depression is left untreated... Your life can become a living nightmare. Depression is a growing epidemic in the US, but it never gets the urgent attention it deserves. You need help and you need it now.

Get My Free Ebook


Post a comment